Medium- and Short-Term Interventions with Ma-Pi 2 Macrobiotic Diet in Type 2 Diabetic Adults of Bauta, Havana
Author(s) -
Carmen Porrata-Maury,
Manuel Hernández Triana,
Eduardo Rodríguez-Sotero,
Raúl Vilá-Dacosta-Calheiros,
Héctor Hernández-Hernández,
Mayelín Mirabal,
Concepción Campa-Huergo,
Mario Pianesi
Publication year - 2012
Publication title -
journal of nutrition and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.789
H-Index - 42
eISSN - 2090-0732
pISSN - 2090-0724
DOI - 10.1155/2012/856342
Subject(s) - medicine , type 2 diabetes , anthropometry , hemoglobin , glycemic , blood pressure , diabetes mellitus , endocrinology , traditional medicine , insulin
Background. In Cuba, the Ma-Pi 2 macrobiotic diet has shown positive results in 6-month assays with type 2 diabetic patients. The objective of this study was to assess the influence of this diet at short and medium terms. Methods. Sixty-five type 2 diabetic volunteers were included for dietary intervention, institutionally based for 21 days and followed later at home, until completing 3 months. 54 of them stayed until assay end. Before intervention, and after both assay periods, they were submitted to anthropometric records, body composition analyses and measurements of serum biochemical indicators, glycemic profile in capillary blood, blood pressure, and medication consumption; food intake was evaluated by the 3-day dietary recall. Results. During the intervention, the energy intake was 200 kcal higher at instance of more complex carbohydrates and dietary fiber and despite less fat and protein. Blood pressure and serum biochemical indicators decreased significantly in both periods; the safety nutritional indicators (hemoglobin, serum total proteins, and albumin) showed no variations. The global cardiovascular risk decreased and insulin consumption dropped by 46% and 64%, in both periods, respectively. Conclusions. The Ma-Pi 2 macrobiotic diet was a successful therapy at short term and after 3-month home-based intervention, for type 2 diabetics.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom